SOLON, OH, Locus Fermentation Solutions, a U.S.-based biotechnology company producing performance-enhancing bio-based additives, announced the close of an oversubscribed $20 million investment in a convertible note round at an equity valuation of $100M led by Hudson Bay Capital.
Continue Reading
Sign up for FREE to read the full article and access 119K+ alternative investment headlines.